PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
Clinical trial NCT04547504 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04547504
- Sponsor
- University Hospital, Brest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2025-12-22
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.